FDA Approved: CAPECITABINE — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for CAPECITABINE submitted by BluePoint Laboratories. The action concerns the generic capecitabine product and its l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Gastric Cancer

Drugs mentioned

• Capecitabine (capecitabine)

Snippet

SUPPL AP for CAPECITABINE (CAPECITABINE)